| EX1742 PRE-ECLAMPSIA SCREENING PANEL |
| Specimen: |
2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| NA |
8 hrs |
12 weeks |
|
| Method: |
ECLIA |
| Comment: |
Also, see PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL. |
| Report: |
Contact us to know the TAT. |
| Usage: |
Pre-eclampsia (PE) risk assessment is done by using an algorithm that combines maternal demographic factors, mean arterial pressure, uterine artery pulsatility index, maternal serum Pregnancy-associated plasma protein-A (PAPP-A) & Placental growth factor (PlGF). The estimated detection rate (DR) of Pre-eclampsia in screening by combining maternal factors with biochemical and biophysical markers is 96% for early-onset PE & 77% for late-onset PE at a false positivity rate of 10%. |
| Doctor Specialty: |
Gynecologist |
| Disease: |
Pre-eclampsia |
| Components: |
Early & late-onset Pre-eclampsia Risk Assessment: * Placental Growth Factor (PlGF) * Pregnancy Associated Plasma Protein A (PAPP-A) |
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
IMMUNOASSAY |
| Pre Test Information: |
The test is valid between 10-13 weeks of gestation. It is mandatory to provide maternal Date of birth (dd/mm/yy); Height, weight, IVF, Smoking, History of blood pressure, Diabetes and Pre-eclampsia in a previous pregnancy, Number of Fetuses (Single/ Twins); Blood pressure measurement for right & left arm; USG for CRL & Uterine artery PI. A duly filled Pre-eclampsia screening form is mandatory. |
Reviews
There are no reviews yet.